Pfizer (NYSE:PFE) has announced PfizerForAll, a new website that will offer vaccines, medical tests and medications delivered at home.
PfizerForAll is designed for patients with migraine, COVID-19 or flu, and adults seeking vaccines for preventable diseases, including COVID-19, flu, RSV and pneumococcal pneumonia.
The platform offers end-to-end services including same-day appointments with a qualified healthcare professional (either in-person or via telehealth), finding and booking vaccines, and at-home delivery of tests and medications or through a preferred pharmacy.
Patients will be able to use existing insurance and pharmacy programs as well as new direct services from partners including UpScriptHealth, Alto Pharmacy and Instacart.
Pfizer has said it will continue to expand and develop PfizerForAll to address a broader range of needs and conditions.
Back in January, fellow drugmaker Eli Lilly (LLY) launched its own website to offer telehealth access and home delivery of drugs.
WW International (WW) and LifeMD (LFMD), down 0.92% premarket, also operate similar offerings. Meanwhile, telehealth platform Hims & Hers Health (HIMS) lost ~5.23% premarket in reaction.
